Ruptured Vertebral Artery Aneurysm in a Patient with Loeys-Dietz Syndrome Type 4: A Sentinel Case Report
Abstract
Loeys-Dietz Syndrome (LDS) is a rare, autosomal dominant connective tissue disorder with an estimated prevalence of less than 1 in 100,000. LDS results from one of several genetic mutations altering the transforming growth factor β (TGF-β) signaling pathway. LDS portends a higher risk of vascular pathology including dissections and aneurysms throughout the arterial system. Though not commonly described, this higher incidence of vascular pathology extends to the cerebrovascular system with several case reports of cerebral aneurysms in patients afflicted with LDS. Herein, we describe the case of a 39-year-old female with a family history of cerebral and aortic aneurysms who presented with acute onset headache, neck pain, and lower extremity paresis prompting a CT head and subsequent magnetic resonance angiogram remarkable for a subarachnoid hemorrhage secondary to rupture of a large fusiform V4 segment vertebral artery aneurysm. Formal angiogram confirmed this diagnosis, and endovascular treatment was pursued with coil embolization of the aneurysm and parent vertebral artery distal occlusion. Subsequent genetic testing confirmed the patient to be positive for the mutation indicative of type 4 LDS. Though rare, LDS should be considered as a possible diagnosis in patients presenting with aneurysmal subarachnoid hemorrhage when a family history of systemic vascular pathology is elicited. Confirmatory diagnosis of LDS appropriately spurs additional vascular imaging and family…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.